| Bioactivity | Nedometinib is a tyrosine kinase inhibitor targeting to MEK1. Nedometinib has antineoplastic effect and can be used for research in dermatosis, cutaneous fibroneuroma, neurofibromatosis[1]. |
| Target | MEK1 |
| Name | Nedometinib |
| CAS | 2252314-46-6 |
| Formula | C17H16FIN4O3 |
| Molar Mass | 470.24 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kincaid, et al. Preparation of pyrrolopyridine-aniline compounds for treatment of dermal disorders. World Intellectual Property Organization, WO2018213810 A1. 2018-11-22. |
Nedometinib
CAS: 2252314-46-6 F: C17H16FIN4O3 W: 470.24
Nedometinib is a tyrosine kinase inhibitor targeting to MEK1. Nedometinib has antineoplastic effect and can be used for
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.